Get the Stockscreener App
0.834
4.24%
-0.0369
After Hours:
.83
-0.004
-0.48%
Lunai Bioworks Inc stock is traded at $0.834, with a volume of 92,589.
It is down -4.24% in the last 24 hours and down -35.35% over the past month.
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
See More
Previous Close:
$0.8709
Open:
$0.8448
24h Volume:
92,589
Relative Volume:
1.41
Market Cap:
$20.19M
Revenue:
-
Net Income/Loss:
$-178.01M
P/E Ratio:
-0.1002
EPS:
-8.326
Net Cash Flow:
$-7.87M
1W Performance:
-19.81%
1M Performance:
-35.35%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.8199
$0.8893
1-Week Range:
$0.811
$1.06
52-Week Range:
$0.811
$1.40
Lunai Bioworks Inc Stock (LNAI) Company Profile
Name
Lunai Bioworks Inc
Sector
Industry
Phone
45 39179840
Address
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare LNAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNAI
Lunai Bioworks Inc
|
0.834 | 20.19M | 0 | -178.01M | -7.87M | -8.326 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lunai Bioworks Inc Stock (LNAI) Latest News
Lunai Bioworks Shareholders Approve Key Proposals - TipRanks
Lunai Bioworks Inc. (LNAI) interactive stock chart - Yahoo! Finance UK
Lunai Bioworks Inc. (LNAI) Stock Forum & Discussion - Yahoo! Finance Canada
Lunai Bioworks announces early results from AI-based platform - MSN
Lunai Bioworks reports promising results from AI platform detecting neurotoxins - Investing.com Australia
Lunai Bioworks : Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds - MarketScreener
Lunai Bioworks receives Nasdaq notice for non-compliance with $35 million market value rule - Investing.com Philippines
Lunai Bioworks Inc (FRA:2Q50) Stock Price & 30 Year Financial Data - GuruFocus
Lunai Bioworks Faces Nasdaq Non-Compliance Notice - TipRanks
LNAI Unveils Early Results from AI-Based Screening for Neurotoxi - GuruFocus
Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds - PharmiWeb.com
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - BlueRidgeNow.com
Lunai Bioworks Inc. (LNAI) company profile and facts - Yahoo! Finance UK
Lunai Bioworks Regains Nasdaq Compliance in October 2025 - The Globe and Mail
Lunai Bioworks regains compliance with Nasdaq minimum bid price rule - MSN
700 serum samples: Lunai Bioworks-led study identifies prognostic DMD biomarkers, RGMA and ANTXR2 - Stock Titan
Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement - PharmiWeb.com
11 business days ≥$1: Lunai Bioworks regains Nasdaq compliance, remains eligible for continued listing - Stock Titan
Nasdaq deficiency lifted as Lunai meets $1.00 bid for 11 days - Stock Titan
Lunai Bioworks Inc.Common Stock (Nasdaq:LNAI) Stock Quote - FinancialContent
Lunai Bioworks Inc. (LNAI) latest stock news and headlines - Yahoo! Finance UK
Lunai Bioworks seeks approval for equity plan to 3,476,722 - Stock Titan
Technical Analysis of Lunai Bioworks Inc. (NASDAQ:LNAI) - TradingView
Lunai Bioworks Inc. (LNAI) stock major holders - Yahoo
Lunai Bioworks Inc. (LNAI) balance sheet - Yahoo
Lunai Bioworks, Inc. News — LSX:A41K8P - TradingView
LNAI (Lunai Bioworks) Equity-to-Asset : -2.59 (As of Jun. 2025) - GuruFocus
LNAI (Lunai Bioworks) Gross Margin % : 0.00% (As of Jun. 2025) - GuruFocus
LNAI (Lunai Bioworks) Other Stockholders Equity : $0.00 Mil (As of Jun. 2025) - GuruFocus
LNAI (Lunai Bioworks) Gross Property, Plant and Equipment : $1.76 Mil (As of Jun. 2025) - GuruFocus
LNAI (Lunai Bioworks) PensionAndRetirementBenefit : $0.00 Mil (As of Jun. 2025) - GuruFocus
LNAI (Lunai Bioworks) Intrinsic Value: DCF (FCF Based) : $-5.70 (As of Oct. 12, 2025) - GuruFocus
LNAI (Lunai Bioworks) Asset Turnover : 0.00 (As of Jun. 2025) - GuruFocus
LNAI (Lunai Bioworks) Buyback Yield % : -9.07 (As of Oct. 11, 2025) - GuruFocus
Lunai Bioworks Inc. (LNAI) - Yahoo
Lunai Bioworks Inc. (LNAI) options chain - Yahoo
Lunai Bioworks Inc. (LNAI) cash flow - Yahoo
Lunai Bioworks Inc. (LNAI) Options Chain - Yahoo
Lunai Bioworks Inc. (LNAI) recent insider transactions - Yahoo
Lunai Bioworks Inc. (LNAI) stock price, news, quote and history - Yahoo
Lunai Bioworks Inc. (LNAI) insider ownership and holdings - Yahoo
Lunai Bioworks Inc. (LNAI) analyst ratings, estimates and forecasts - Yahoo
Lunai Bioworks Inc. (LNAI) Valuation Measures & Financial Statistics - Yahoo
LNAI (Lunai Bioworks) PS Ratio : (As of Oct. 08, 2025) - GuruFocus
Lunai Bioworks Inc. (LNAI) Insider Ownership & Holdings - Yahoo
Lunai Bioworks Inc. (LNAI) Recent Insider Transactions - Yahoo
Lunai Bioworks Inc. (LNAI) Stock Price, News, Quote & History - Yahoo! Finance Canada
LNAI Interactive Stock Chart | Lunai Bioworks Inc. Stock - Yahoo Finance
Lunai Bioworks Inc. (LNAI) Latest Stock News & Headlines - Yahoo
Lunai Bioworks Inc. (LNAI) Interactive Stock Chart - Yahoo
Lunai Bioworks reports 35% improvement in Alzheimer’s diagnostics - Investing.com
Lunai Bioworks Inc Stock (LNAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):